226 related articles for article (PubMed ID: 20824139)
1. Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
Benny O; Nakai K; Yoshimura T; Bazinet L; Akula JD; Nakao S; Hafezi-Moghadam A; Panigrahy D; Pakneshan P; D'Amato RJ
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824139
[TBL] [Abstract][Full Text] [Related]
2. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.
Benny O; Fainaru O; Adini A; Cassiola F; Bazinet L; Adini I; Pravda E; Nahmias Y; Koirala S; Corfas G; D'Amato RJ; Folkman J
Nat Biotechnol; 2008 Jul; 26(7):799-807. PubMed ID: 18587385
[TBL] [Abstract][Full Text] [Related]
3. Evolving multidimensional pharmacological approaches to CNV therapy in AMD.
Ehrenberg M; Benny O
Curr Eye Res; 2018 Feb; 43(2):147-154. PubMed ID: 29111834
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
5. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis research. Cancer drugs found to work in new way.
Barinaga M
Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
[No Abstract] [Full Text] [Related]
7. Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
Wang WQ; Wang FH; Qin WX; Liu HY; Lu B; Chung C; Zhu J; Gu Q; Shi W; Wen C; Wu F; Zhang K; Sun XD
Mol Pharm; 2016 Sep; 13(9):2881-90. PubMed ID: 27089240
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration.
Liang IC; Ko WC; Hsu YJ; Lin YR; Chang YH; Zong XH; Lai PC; Chang DC; Hung CF
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769482
[TBL] [Abstract][Full Text] [Related]
9. Anti-VEGF agents for age-related macular degeneration.
Ozkiris A
Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.
Cloutier F; Lawrence M; Goody R; Lamoureux S; Al-Mahmood S; Colin S; Ferry A; Conduzorgues JP; Hadri A; Cursiefen C; Udaondo P; Viaud E; Thorin E; Chemtob S
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1195-203. PubMed ID: 22323484
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Eyetech Study Group
Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
[TBL] [Abstract][Full Text] [Related]
12. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
13. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
14. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
15. Promising new treatments for neovascular age-related macular degeneration.
Michels S; Schmidt-Erfurth U; Rosenfeld PJ
Expert Opin Investig Drugs; 2006 Jul; 15(7):779-93. PubMed ID: 16787141
[TBL] [Abstract][Full Text] [Related]
16. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Lu X; Sun X
Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of the anti-angiogenesis drug TNP-470.
Gervaz P; Fontolliet C
Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
[TBL] [Abstract][Full Text] [Related]
19. Hitting the mother lode of tumor angiogenesis.
James D; Rabbany S; Rafii S
Nat Biotechnol; 2008 Jul; 26(7):769-70. PubMed ID: 18612297
[No Abstract] [Full Text] [Related]
20. Current therapeutic approaches in neovascular age-related macular degeneration.
Nguyen DH; Luo J; Zhang K; Zhang M
Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]